SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 442.05 |
| Enterprise Value ($M) | 361.03 |
| Book Value ($M) | 465.09 |
| Book Value / Share | 7.56 |
| Price / Book | 0.95 |
| NCAV ($M) | 449.17 |
| NCAV / Share | 7.31 |
| Price / NCAV | 0.98 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.84 |
| Return on Assets (ROA) | -0.45 |
| Return on Equity (ROE) | -0.50 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.42 |
| Current Ratio | 7.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 531.30 |
| Assets | 547.22 |
| Liabilities | 82.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 41.24 |
| Operating Income | -410.52 |
| Net Income | -400.67 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -267.19 |
| Cash from Investing | 266.68 |
| Cash from Financing | 10.66 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rtw Investments, Lp | 4.90 | -42.23 | |
| 13G/A | Fmr Llc | 6.70 | -21.89 | |
| 13G | Morgan Stanley | 7.40 | ||
| 13G/A | Vanguard Group Inc | 7.90 | -16.01 | |
| 13G/A | Bb Biotech Ag | 1.90 | -73.58 | |
| 13D | Biogen Inc. | 10.20 | 0.00 | |
| 13G/A | BlackRock, Inc. | 8.80 | 0.00 | |
| 13G/A | State Street Corp | 4.80 | -25.32 | |
| 13G/A | Wellington Management Group Llp | 0.07 | -99.34 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 145,531 | 835,166 | 17.43 | |
| 66,220 | 560,613 | 11.81 | |
| 78,339 | 918,044 | 8.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RNA – Avidity Biosciences, Inc. | RNAC – Cartesian Therapeutics, Inc. |
| RYTM – Rhythm Pharmaceuticals, Inc. | SCYX – SCYNEXIS, Inc. |
| SGMT – Sagimet Biosciences Inc. |
Financial data and stock pages provided by
Fintel.io